Please Wait...

Tanja Schubert

Translation skills

Main profile

Tanja Schubert, Ph.D.
VP & General Manager Biochemical Markers

Dr. Schubert leads the Molecular Marker practice at Bioclinica and is responsible for all operational and organizational activities, overseeing service quality, study management, process improvements and regulatory compliance. She is actively engaged in business development and client discussions advising in implementing biochemical markers in clinical trials. Dr. Schubert oversees the laboratory activities and serves as accredited Laboratory Director for the College of American Pathologists. Prior to her current position, Dr. Schubert joined legacy Synarc Laboratory in 2006 as Head of the Project Management Department and was responsible for all operational aspects of a clinical trial management.

Dr. Schubert is a trained Pharmacist and received a PhD in Natural Sciences from the Ludwig-Maximilians-Universität in Munich, Germany.

Blogs

CSF biomarkers & Alzheimer's Disease

The Importance of Early Diagnosis for AD Last month, scientists, clinicians, drug sponsors, and regulators gathered in our nation's capital at the annual Alzheimer's Association International Conference (AAIC) to share recent advances in AD research and clinical drug development.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Still time to catch up on summer reading on recent developments in #Alzheimer's Disease Fluid Biomarkers here int t… https://t.co/kyQmz7FxlN
bioclinica (2 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still other organizations remain… https://t.co/UwVs6ajPp4
bioclinica (3 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still some in the industry remai… https://t.co/ASuUvN6xb9
bioclinica (5 days ago)
RT @RfwrightLSL: When Do You Think #BYOD (Bring Your Own Device) Will Become Widely Used To Capture PRO Data In #Clinical #Research? https:…
bioclinica (2 weeks ago)
ICYMI: Our V.P./Head of Neuroscience & Cardiovascular Svcs., Dr. Joyce Suhy, talks about challenges in determining… https://t.co/Lns6B3VPPN
bioclinica (2 weeks ago)
RT @FCR_News_Today: FDA Issues New Guides on Use of Electronic Health Information in #ClinicalTrials. #ClinicalResearch https://t.co/j8LHV2…
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen